{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Burn", "Itch", "Pruritus"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "38097439", "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "10", "Day": "05"}], "ELocationID": ["10.1016/j.burns.2023.09.012", "S0305-4179(23)00188-2"], "Journal": {"ISSN": "1879-1409", "JournalIssue": {"Volume": "50", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Burns : journal of the International Society for Burn Injuries", "ISOAbbreviation": "Burns"}, "ArticleTitle": "Treatment of post-burn pruritus - A systematic review and meta-analysis.", "Pagination": {"StartPage": "293", "EndPage": "301", "MedlinePgn": "293-301"}, "Abstract": {"AbstractText": ["Post-burn pruritus is one of the most common complaints reported by patients with limited evidence for a gold-standard treatment.", "To review the literature and assess the efficacy of various interventions in treating post-burn pruritus.", "PubMed, MEDLINE, CINAHL, Web of Sciences, Ovid Databases, and ClinicalTrials.Gov were searched. The articles were scored by two assessors for inclusion with a third independent assessor resolving conflicting scores.", "The present systematic review and meta-analysis synthesised findings from a total of nine studies, representing a pool of 323 patients. The standardized mean effect size for the various categories of interventions was: naltrexone at 1.47 (95 % CI of 0.75-2.20, p\u00a0<\u00a00.0000), coverings at 0.94 (95 % CI of 0.40-1.48, p\u00a0=\u00a00.006), topical ozonated oil at 2.64 (95 % CI of 1.94-3.34, p\u00a0<\u00a00.00001), lasers at 2.34 (95 % CI of 1.60-3.09, p\u00a0<\u00a00.00001), current stimulation at 1.03 (95 % CI of -0.04 to 2.10, p\u00a0=\u00a00.06), and lemon balm tea at 0.54 (95% CI of 0.12-0.96, p\u00a0=\u00a00.01).", "Current evidence suggests that current modalities have a statistically significant, but not clinically significant, reduction in pruritus. This review highlights the limited quality of evidence in the literature and the poor quality of reporting among excluded studies."], "CopyrightInformation": "Copyright \u00a9 2023 Elsevier Ltd and ISBI. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: luisandrade@med.miami.edu."}], "LastName": "Andrade", "ForeName": "Luis F", "Initials": "LF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Memorial University Faculty of Medicine, St. Johns, NL, Canada."}], "LastName": "Abdi", "ForeName": "Parsa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chicago College of Osteopathic Medicine, Downers Grove, IL, USA."}], "LastName": "Kooner", "ForeName": "Amritpal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Al-Azhar University, Faculty of Medicine, Cairo, Egypt."}], "LastName": "Eldaboush", "ForeName": "Ahmed Monib", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Nevada, Reno School of Medicine, Reno, NV, USA."}], "LastName": "Dhami", "ForeName": "Ramneek K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Morsani College of Medicine, Tampa, FL, USA."}], "LastName": "Natarelli", "ForeName": "Nicole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA."}], "LastName": "Yosipovitch", "ForeName": "Gil", "Initials": "G"}], "PublicationTypeList": ["Meta-Analysis", "Systematic Review", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Burns", "NlmUniqueID": "8913178", "ISSNLinking": "0305-4179"}, "CoiStatement": "Declaration of Competing Interest Yosipovitch; Abbvie, Arcutis, BMS, Cara Therapuetics, GSK. Escient Health, Eli Lilly, Galderma, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regen-eron Pharmaceuticals, Inc., Sanofi, TreviTherapeutics, Vifor \u2013 advisory board member; Eli Lilly, Kiniksa Pharmaceuticals, LEO Pharma, Novartis, Pfizer, Galderma, Escient, Sanofi Regeneron, Celldex \u2013 grants/research funding; Regeneron Pharmaceuticals, Inc., Sanofi \u2013 investigator."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "6", "Day": "17"}, {"Year": "2023", "Month": "8", "Day": "22"}, {"Year": "2023", "Month": "9", "Day": "22"}, {"Year": "2024", "Month": "2", "Day": "26", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "15", "Hour": "0", "Minute": "44"}, {"Year": "2023", "Month": "12", "Day": "14", "Hour": "21", "Minute": "59"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38097439", "10.1016/j.burns.2023.09.012", "S0305-4179(23)00188-2"]}}], "PubmedBookArticle": []}